Preclinical Phase · Consistent Results

Meet
ALPS™

Living energy with every heartbeat. An autonomous leadless pacing system designed for long-term energy autonomy.

Scroll

Discover the technology Watch expert interview

CAIRDAC is developing ALPS™,
a leadless pacing system designed
to harvest cardiac kinetic energy
and reduce dependence on
battery-limited architectures.

A patented kinetic energy harvesting technology synchronized with cardiac rhythm, designed to support long-term device operation.

Self-Sustaining Energy

Patented technology is designed to harvest the heart's own kinetic energy and support long-term energy autonomy.

Leadless & Transcatheter

A miniature form factor designed for minimally invasive transcatheter implantation, reducing the risks associated with leads and generator pockets.

Advanced Pacing Architecture

ALPS™ is designed to support multi-chamber pacing capabilities in a leadless platform while reducing battery-driven trade-offs associated with conventional leadless architectures.

Rigorous Evidence

Currently in chronic preclinical testing, ALPS™ is building a rigorous evidence base to support clinical translation.

Clinical Impact

From leadless pacing to continuous
cardiac patient management

CAIRDAC is developing ALPS™, a leadless pacing platform designed to combine the safety advantages of leadless therapy with continuous remote monitoring and long-term patient management capabilities. By reducing battery-driven trade-offs, ALPS™ is intended to support long-term therapy continuity, richer patient data, and earlier detection of clinically relevant events.

Continuous monitoring. Designed to support alerts and longitudinal patient management.

Smarter follow-up. Intended to reduce unnecessary hospital visits while providing clinicians with richer patient data.

Future diagnostic potential. Platform architecture designed to support future clinically relevant parameters.

ALPS™ in situ Autonomous Leadless Pacing System

Why ALPS™
changes everything

1st

Autonomous Leadless Pacing System worldwide, a category-defining innovation in cardiac rhythm management.

Battery-driven replacement surgeries targeted. Conventional and leadless pacemakers may require replacement procedures during a patient's lifetime.

Dual-chamber capability with energy autonomy. ALPS™ is designed to support multi-chamber leadless pacing while reducing the battery-driven trade-offs associated with conventional leadless architectures.

∞

Designed for long-term energy autonomy. Kinetic harvesting from the heart's own movement is intended to support continuous device operation.

Expert Opinion

Prof. Wouter
Oosterlinck M.D, Ph.D.

"The self-sustaining energy supply of ALPS™ addresses the currently unmet fundamental needs in cardiac rhythm disorders — from device longevity to dual-chamber stimulation and lower risks of infection."

Prof. Wouter Oosterlinck M.D, Ph.D. University Hospitals Leuven, Belgium